GO:0031591 wybutosine biosynthetic process: tRNA Modification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031591 describes the biosynthesis of wybutosine (yW), a hypermodified guanosine derivative found at position 37 of tRNA(Phe) in eukaryotes and archaea.
• Wybutosine biosynthesis proceeds through a conserved multi-step pathway involving radical SAM enzymes and methyltransferases, with TYW1, TYW2, TYW3, TYW4, and TYW5 as key players.
• The wybutosine modification stabilizes codon-anticodon interactions and supports accurate ribosomal translocation during protein synthesis.
• Loss of wybutosine or its biosynthetic enzymes has been linked to translation dysregulation, which can produce targetable antigens in cancer.
• Detection of wybutosine-modified tRNA(Phe) can be achieved by HCl/aniline cleavage followed by nonradioactive Northern hybridization.
• Emerging nanopore sequencing approaches enable direct tRNA modification profiling, including wybutosine, in human cancer models.
Description
Wybutosine (yW) is a complex modified nucleoside that occurs at position 37 of tRNA(Phe) in eukaryotes and archaea, and its biosynthesis is captured by the Gene Ontology term GO:0031591 (wybutosine biosynthetic process). This modification is essential for translational fidelity because it reinforces codon-anticodon pairing and influences the accuracy of ribosomal translocation. Researchers study wybutosine biosynthesis to understand how tRNA modifications shape the proteome and how their disruption contributes to disease, particularly cancer. The pathway involves a series of enzymatic reactions that convert an initial guanosine derivative into the final wybutosine structure through radical-mediated chemistry and methylation steps. Because wybutosine is a hallmark of tRNA(Phe) maturation, its detection serves as a readout for tRNA nuclear import and re-export defects. Recent advances in nanopore sequencing now allow direct interrogation of tRNA modifications, including wybutosine, in human cancer models, opening new avenues for biomarker discovery.
wybutosine biosynthetic process At A Glance
| GO ID | GO:0031591 |
|---|---|
| GO term | wybutosine biosynthetic process |
| Ontology | biological_process |
| Synonym | yW biosynthesis; yW biosynthetic process |
| Definition | The chemical reactions and pathways resulting in the formation of wybutosine, a modified nucleoside found in some tRNA molecules. |
| Major function | Production of wybutosine, a hypermodified base at position 37 of tRNA(Phe) that stabilizes codon-anticodon interactions and supports translational fidelity. |
| Key enzymes | TYW1, TYW2, TYW3, TYW4, TYW5 (and homologs). |
| Cellular location | Nucleus and cytoplasm (tRNA modification occurs in multiple compartments). |
| Related disease | Cancer, through translation dysregulation and production of targetable antigens. |
What Is GO:0031591?
GO:0031591, wybutosine biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of wybutosine, a modified nucleoside found in some tRNA molecules. Wybutosine is chemically described as 3H-imidazo[1,2-alpha]purine-7-butanoic acid, 4,9-dihydro-alpha-[(methoxycarbonyl)amino]-4,6-dimethyl-9-oxo-3-beta-D-ribofuranosyl methyl ester. The term is also known by the synonyms yW biosynthesis and yW biosynthetic process. This process occurs in the nucleus and cytoplasm of eukaryotic cells and involves multiple enzymatic steps that modify a guanosine residue at position 37 of tRNA(Phe).
Why Is wybutosine biosynthetic process Important in Cell Biology?
Wybutosine biosynthesis is critical for translational accuracy because the wybutosine modification at tRNA(Phe) position 37 prevents frameshifting and ensures efficient codon-anticodon pairing. Disruption of this pathway leads to translation dysregulation, which can expose novel antigens in cancer cells and is being explored for immunotherapy. Moreover, the enzymes involved in wybutosine biosynthesis are conserved across eukaryotes and archaea, making them valuable models for studying radical SAM chemistry and tRNA modification circuits. Understanding this process also has clinical implications because tRNA modification defects are increasingly recognized in cancer and other diseases.
• Ensures translational fidelity by stabilizing codon-anticodon interactions at the ribosomal A-site.
• Prevents frameshifting during protein synthesis, which is vital for proteome integrity.
• Loss of wybutosine leads to translation dysregulation that can generate targetable antigens in cancer.
• Provides a model for radical SAM enzyme mechanisms and hypermodification chemistry.
• Serves as a readout for tRNA nuclear import and re-export defects.
• Enables studies of tRNA modification circuits in the anticodon loop.
• Offers potential biomarkers for cancer diagnosis and prognosis through nanopore sequencing.
• Highlights the role of tRNA modifications in human disease and ribosomopathies.
What Happens During wybutosine biosynthetic process?
Initial formation of the wybutosine precursor
In simple terms: The cell first builds a simplified version of wybutosine on tRNA(Phe).
The biosynthesis of wybutosine begins with the modification of a guanosine residue at position 37 of tRNA(Phe). The first committed step involves the radical SAM enzyme TYW1, which catalyzes the formation of the tricyclic ring system using S-adenosylmethionine and a [4Fe-4S] cluster. This step produces the intermediate 4-demethylwyosine (imG-14), which serves as the scaffold for subsequent modifications.
Methylation and side-chain elaboration
In simple terms: Enzymes then add methyl groups and build the side chain to complete wybutosine.
Following the formation of 4-demethylwyosine, TYW2 (also known as TYW2/TRM12) adds a 4-demethylwyosine alpha-amino-alpha-carboxypropyl group, yielding 7-aminocarboxypropyl-demethylwyosine (yW-86). TYW3 then methylates the 4-demethyl position to produce 7-aminocarboxypropylwyosine (yW-72), and TYW4 (TYW4/TRM12) catalyzes the final methylation and methoxycarbonylation steps to form wybutosine. In some organisms, TYW5 is involved in hydroxylation or further modification.
Radical SAM chemistry and ring formation
In simple terms: A radical-based reaction creates the unusual ring structure of wybutosine.
The radical SAM enzyme TYW1 uses a reductive cleavage of S-adenosylmethionine to generate a 5'-deoxyadenosyl radical, which abstracts a hydrogen atom from the substrate to initiate ring closure. This radical-mediated cyclization is a key step in forming the tricyclic core of wybutosine. The reaction requires anaerobic conditions and electron donors such as flavodoxin or ferredoxin.
Final maturation and tRNA incorporation
In simple terms: The finished wybutosine is installed on tRNA and the tRNA is ready for translation.
After the final enzymatic steps, wybutosine is fully assembled on tRNA(Phe). The modified tRNA is then exported to the cytoplasm for use in translation. The presence of wybutosine at position 37 stabilizes the anticodon loop and ensures accurate decoding of phenylalanine codons.
Key Genes Involved in GO:0031591 wybutosine biosynthetic process
The following genes and their protein products are central to wybutosine biosynthesis, as established in the literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TYW1 | Radical SAM enzyme that catalyzes the initial ring formation in wybutosine biosynthesis | Key target for studying radical SAM chemistry and tRNA modification |
| TYW2 | Adds the alpha-amino-alpha-carboxypropyl group to form yW-86 intermediate | Involved in methyltransferase-like reactions; potential cancer biomarker |
| TYW3 | Methylates the 4-demethyl position to produce yW-72 | Part of the conserved wybutosine biosynthetic pathway |
| TYW4 | Catalyzes final methylation and methoxycarbonylation to form wybutosine | Essential for complete wybutosine synthesis; linked to translation fidelity |
| TYW5 | Hydroxylase or modifying enzyme in some organisms | May contribute to wybutosine diversity |
| TRM12 | Yeast homolog of TYW2/TYW4 involved in wybutosine biosynthesis | Model for studying tRNA modification in Saccharomyces cerevisiae |
| PUS7 | Pseudouridine synthase that may interact with wybutosine pathway | Potential cross-talk in tRNA modification circuits |
| DKC1 | Pseudouridine synthase associated with ribosome biogenesis | May influence tRNA modification and translation |
| FTSJ1 | 2'-O-methyltransferase that modifies tRNA | Related to tRNA modification networks |
| ALKBH8 | Alkylation repair protein that also modifies tRNA | Connects tRNA modifications to stress responses |
| METTL1 | Methyltransferase that modifies tRNA | Part of the broader tRNA modification landscape |
| WDR4 | Partner of METTL1 in tRNA methylation | Implicated in tRNA modification and disease |
| NSUN2 | tRNA methyltransferase | Affects tRNA stability and translation |
| ELP1 | Component of the Elongator complex that modifies tRNA wobble position | Links tRNA modifications to neurological disease |
| CTU1 | Thiolation enzyme for tRNA | Part of the tRNA modification network |
| CTU2 | Thiolation enzyme for tRNA | Interacts with wybutosine pathway components |
| TRMT5 | tRNA methyltransferase | Involved in tRNA modification and translation |
| TRMT6 | tRNA methyltransferase | Contributes to tRNA modification circuits |
How Is wybutosine biosynthetic process Regulated?
The wybutosine biosynthetic process is regulated at multiple levels. The expression of TYW enzymes is coordinated with tRNA transcription and processing, and the pathway is sensitive to cellular metabolic status. Retrograde tRNA nuclear import and re-export can influence the availability of tRNA(Phe) for modification, and defects in this process can be detected by wybutosine levels. Additionally, tRNA modification circuits in the anticodon loop, including wybutosine, are interconnected with other modifications such as pseudouridylation and methylation, suggesting a regulatory network that ensures translational fidelity. In cancer, dysregulation of tRNA modifications, including wybutosine, can lead to translation reprogramming and the presentation of novel antigens.
wybutosine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TYW1 | Cancer, translation dysregulation | Knockout in cancer cell lines followed by Ribo-seq |
| TYW2 | Cancer, tRNA modification changes | Point mutation to abrogate enzymatic activity |
| TYW3 | Developmental defects (hypothetical) | Knock-in of patient variants in zebrafish |
| TYW4 | Ribosomopathy-like phenotypes | Overexpression and knockout in HEK293T |
| TYW5 | Neurological disorders (potential) | Conditional knockout in mouse neurons |
Cancer and translation dysregulation
Alterations in tRNA modifications, including wybutosine biosynthesis, can cause translation dysregulation that produces aberrant peptides presented on MHC molecules, making them targetable by immunotherapy. Nanopore sequencing of tRNA from human cancer models has revealed dynamic changes in modification profiles, including wybutosine, suggesting potential as cancer biomarkers.
Neurological disorders and tRNA modification defects
Mutations in tRNA modification enzymes, such as those in the Elongator complex, are linked to neurological disorders like familial dysautonomia and intellectual disability. Although wybutosine-specific defects are not yet directly linked to these diseases, the broader tRNA modification network is critical for neuronal function.
Ribosomopathies and translational stress
Defects in ribosome biogenesis and tRNA modification can lead to ribosomopathies, which often present with bone marrow failure and developmental abnormalities. Wybutosine biosynthesis contributes to translational accuracy, and its disruption may exacerbate ribosomal stress.
From wybutosine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TYW1 knockout reduce wybutosine levels? | CRISPR knockout in HeLa or HEK293T cells |
| Does a point mutation in TYW2 affect enzymatic activity? | CRISPR point mutation knock-in of catalytic residue |
| Can wybutosine biosynthesis be monitored in live cells? | Knock-in of fluorescent tag on TYW4 |
| Does overexpression of TYW enzymes increase wybutosine? | Overexpression constructs in yeast or human cells |
| What is the role of wybutosine in cancer antigen presentation? | Knockout of TYW1 in melanoma cells followed by immunopeptidomics |
| How does wybutosine affect ribosomal translocation? | In vitro translation with modified tRNA and ribosome structural studies |
How to Study the wybutosine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HCl/aniline cleavage + Northern blot | Presence of wybutosine-modified tRNA(Phe) | Monitoring tRNA nuclear import/export defects |
| Nanopore sequencing | tRNA modification profiles including wybutosine | Cancer model profiling |
| Ribo-seq | Ribosome occupancy and translation efficiency | Assessing translation dysregulation |
| LC-MS/MS | Quantification of wybutosine and intermediates | Enzyme activity assays |
| In vitro translation | Fidelity of codon-anticodon pairing | Studying ribosomal translocation |
| CRISPR knockout screening | Identification of genes required for wybutosine biosynthesis | Functional genomics |
| Structural biology (cryo-EM) | Mechanism of ribosome translocation with modified tRNA | Understanding accuracy mechanism |
| Immunopeptidomics | MHC-presented peptides from translation dysregulation | Cancer antigen discovery |
Detection of wybutosine by HCl/aniline cleavage
Wybutosine-modified tRNA(Phe) can be specifically detected using HCl/aniline cleavage followed by nonradioactive Northern hybridization. This method exploits the acid-labile nature of wybutosine, which leads to a specific cleavage product that can be visualized.
Nanopore sequencing for tRNA modification profiling
Nanopore sequencing enables direct reading of tRNA modifications, including wybutosine, by detecting characteristic current disruptions. This approach has been applied to human cancer models to profile tRNA modification landscapes.
Ribosome profiling (Ribo-seq) to assess translation fidelity
Ribo-seq measures ribosome occupancy and can reveal changes in translation elongation or frameshifting when wybutosine biosynthesis is disrupted. This is particularly useful in cancer cells where translation dysregulation is common.
Mass spectrometry for nucleoside analysis
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) can quantify wybutosine and its intermediates directly from tRNA hydrolysates, providing a sensitive readout of pathway activity.
How CRISPR Can Be Used to Study GO:0031591 wybutosine biosynthetic process
Knockout
CRISPR knockout of TYW1, TYW2, TYW3, TYW4, or TYW5 can abolish wybutosine biosynthesis, leading to unmodified tRNA(Phe) and potential translation defects. These models are valuable for studying the consequences of loss of wybutosine on cellular fitness and cancer antigen presentation.
Point Mutation
Introducing point mutations in catalytic residues of TYW enzymes (e.g., the radical SAM domain of TYW1) allows precise dissection of enzymatic steps without completely eliminating protein expression. Such models help distinguish between catalytic activity and structural roles.
Knock-in
Knock-in of epitope tags or fluorescent proteins at endogenous TYW loci enables real-time tracking of enzyme localization and dynamics. This is particularly useful for studying the nuclear-cytoplasmic trafficking of tRNA modification enzymes.
Overexpression
Overexpression of wild-type or mutant TYW enzymes can reveal gain-of-function phenotypes and saturate the wybutosine biosynthesis pathway. This approach is useful for biochemical purification and structural studies.
How EDITGENE Supports wybutosine biosynthetic process Research
Researchers studying wybutosine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in tRNA modification, translation fidelity, or disease phenotypes. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for wybutosine biosynthetic process research.
Frequently Asked Questions About wybutosine biosynthetic process
What is wybutosine biosynthetic process?
Wybutosine biosynthetic process (GO:0031591) is the set of chemical reactions that produce wybutosine, a modified nucleoside found at position 37 of tRNA(Phe), which stabilizes codon-anticodon interactions.
What genes are involved in wybutosine biosynthetic process?
Key genes include TYW1, TYW2, TYW3, TYW4, and TYW5, which encode enzymes that catalyze sequential steps in wybutosine formation.
Where does wybutosine biosynthesis occur?
Wybutosine biosynthesis occurs in the nucleus and cytoplasm, as tRNA(Phe) is modified during its maturation and nuclear export.
Why is wybutosine important for translation?
Wybutosine at position 37 of tRNA(Phe) reinforces codon-anticodon pairing and prevents frameshifting, ensuring accurate protein synthesis.
How can I detect wybutosine in tRNA?
Wybutosine can be detected by HCl/aniline cleavage followed by Northern hybridization, or by nanopore sequencing and mass spectrometry.
Is wybutosine biosynthesis linked to cancer?
Yes, dysregulation of tRNA modifications including wybutosine can lead to translation dysregulation and the production of targetable antigens in cancer.
What are the synonyms for wybutosine biosynthetic process?
The synonyms are yW biosynthesis and yW biosynthetic process.
Which enzymes catalyze wybutosine biosynthesis?
TYW1 is a radical SAM enzyme that initiates ring formation, while TYW2, TYW3, TYW4, and TYW5 catalyze subsequent methylation and modification steps.
Can CRISPR be used to study wybutosine biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the function of TYW genes and their role in translation.
What diseases are associated with defects in wybutosine biosynthesis?
Defects in tRNA modifications, including wybutosine, have been linked to cancer, neurological disorders, and ribosomopathies.
Conclusion
The wybutosine biosynthetic process (GO:0031591) is a conserved pathway that installs a critical modification on tRNA(Phe), ensuring translational fidelity and preventing frameshifting. Its enzymes, including TYW1-TYW5, are attractive targets for studying radical SAM chemistry and tRNA modification networks. Disruption of this pathway has implications for cancer and other diseases, making it a fertile area for CRISPR-based research and therapeutic development.
References
- 1. Weller C et al.. 2025. Translation dysregulation in cancer as a source for targetable antigens.. Cancer Cell 43(5):823-840.e18 PMID: 40154482
- 2. Perche-Letuvée P et al.. 2014. Wybutosine biosynthesis: structural and mechanistic overview.. RNA Biol 11(12):1508-18 PMID: 25629788
- 3. Kochavi A et al.. 2025. Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models.. NAR Cancer 7(4):zcaf044 PMID: 41190243
- 4. Tuorto F et al.. 2016. Genome recoding by tRNA modifications.. Open Biol 6(12) PMID: 27974624
- 5. Djumagulov M et al.. 2021. Accuracy mechanism of eukaryotic ribosome translocation.. Nature 600(7889):543-546 PMID: 34853469
- 6. Nostramo RT et al.. 2023. A Simple Method for the Detection of Wybutosine-Modified tRNA(Phe)(GAA) as a Readout of Retrograde tRNA Nuclear Import and Re-export: HCl/Aniline Cleavage and Nonradioactive Northern Hybridization.. Methods Mol Biol 2666:1-14 PMID: 37166653
- 7. Young AP et al.. 2013. Radical mediated ring formation in the biosynthesis of the hypermodified tRNA base wybutosine.. Curr Opin Chem Biol 17(4):613-8 PMID: 23856057
- 8. Han L et al.. 2018. A rationale for tRNA modification circuits in the anticodon loop.. RNA 24(10):1277-1284 PMID: 30026310
